Asthma/COPD:

Indications for TUDORZA PRESSAIR:

Long-term, maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.

Adult:

400mcg twice daily.

Children:

Not established.

Contraindications:

Milk protein sensitivity.

Warnings/Precautions:

Not for initial treatment of acute episodes of bronchospasm. Narrow-angle glaucoma. Urinary retention. Discontinue immediately if hypersensitivity reactions occur; consider alternative therapy. Labor & delivery. Pregnancy (Cat.C). Nursing mothers.

Pharmacologic Class:

Anticholinergic.

Interactions:

Avoid concomitant anticholinergic agents.

Adverse Reactions:

Headache, nasopharyngitis, cough, diarrhea, sinusitis; paradoxical bronchospasm.

Generic Availability:

NO

How Supplied:

Dry powder inhaler—60 doses

Pricing for TUDORZA PRESSAIR

60 doses of 400mcg inhaler (Qty: 1)
Appx. price $359
GoodRx